Massimo Riccaboni
Titolo
Citata da
Citata da
Anno
The productivity crisis in pharmaceutical R&D
F Pammolli, L Magazzini, M Riccaboni
Nature reviews Drug discovery 10 (6), 428-438, 2011
8692011
A comparison of US and European university-industry relations in the life sciences
J Owen-Smith, M Riccaboni, F Pammolli, WW Powell
Management science 48 (1), 24-43, 2002
7092002
Technological change and network dynamics: lessons from the pharmaceutical industry
L Orsenigo, F Pammolli, M Riccaboni
Research policy 30 (3), 485-508, 2001
5502001
Innovation and corporate growth in the evolution the pharmaceutical industry
G Bottazzi, G Dosi, F Pammolli, M Riccaboni
International Journal of Industrial Organization 19 (7), 1161-1187, 2000
472*2000
Does co-location matter for formal knowledge collaboration in the Swedish biotechnology–pharmaceutical sector?
M McKelvey, H Alm, M Riccaboni
Research policy 32 (3), 483-501, 2003
3432003
The growth of business firms: Theoretical framework and empirical evidence
D Fu, F Pammolli, SV Buldyrev, M Riccaboni, K Matia, K Yamasaki, ...
Proceedings of the National Academy of Sciences 102 (52), 18801-18806, 2005
2262005
matia, K., Yamasaki, K., Stanley, HE (2005): The growth of business firms: Theoretical framework and empirical evidence
D Fu, F Pammoli, SV Buldyrev, M Riccaboni
PNAS 102, 18801-18806, 0
226*
Reputation and impact in academic careers
AM Petersen, S Fortunato, RK Pan, K Kaski, O Penner, A Rungi, ...
Proceedings of the National Academy of Sciences 111 (43), 15316-15321, 2014
1882014
Persistence and uncertainty in the academic career
AM Petersen, M Riccaboni, HE Stanley, F Pammolli
Proceedings of the National Academy of Sciences 109 (14), 5213-5218, 2012
1222012
The sustainability of European health care systems: beyond income and aging
F Pammolli, M Riccaboni, L Magazzini
The European Journal of Health Economics 13 (5), 623-634, 2012
1212012
World input-output network
F Cerina, Z Zhu, A Chessa, M Riccaboni
PloS one 10 (7), e0134025, 2015
1172015
Innovation and competitiveness in European biotechnology
F Pammolli, A Allansdottir, A Bonaccorsi, A Gambardella, M Mariani, ...
Office for Official Publications of the European Communities, 2002
1172002
Dynamic competition in pharmaceuticals
L Magazzini, F Pammolli, M Riccaboni
The European Journal of Health Economics, formerly: HEPAC 5 (2), 175-182, 2004
1132004
Medical devices competitiveness and impact on public health expenditure
F Pammolli, M Riccaboni, C Oglialoro, L Magazzini, G Baio, N Salerno
1032005
Pammolli F.-Riccaboni M.-Stanley HE (2008)." On the size distribution of business firms
J Growiec
Economics Letters 98, 207-212, 0
102*
The evolution of knowledge and the dynamics of an industry network
L Orsenigo, F Pammolli, M Riccaboni, A Bonaccorsi, G Turchetti
Journal of Management & Governance 1 (2), 147-175, 1997
971997
On firm growth in networks
M Riccaboni, F Pammolli
Research Policy 31 (8-9), 1405-1416, 2002
942002
Evolution of controllability in interbank networks
D Delpini, S Battiston, M Riccaboni, G Gabbi, F Pammolli, G Caldarelli
Scientific reports 3, 1626, 2013
882013
Is Europe evolving toward an integrated research area?
A Chessa, A Morescalchi, F Pammolli, O Penner, AM Petersen, ...
Science 339 (6120), 650-651, 2013
882013
Betweenness centrality of fractal and nonfractal scale-free model networks and tests on real networks
M Kitsak, S Havlin, G Paul, M Riccaboni, F Pammolli, HE Stanley
Physical Review E 75 (5), 056115, 2007
862007
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20